We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Japan Mulls Longer Drug Patents

Law360 (May 17, 2005, 12:00 AM EDT) -- Japan is considering an extension of drug parents from the current six years to eight years, according to a published report.

Japan's Ministry of Health, Labour and Welfare is considering whether to extend the the country's patent protection period for new drug products in order to provide manufacturers with better research incentives and profits, the Nihon Keizai Shimbun reported.

Sales of generic versions are banned for six years in Japan, during which new drugs enjoy high government-set prices.

Comparable protection in major European countries covers about...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.